DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Divis Labs Share Price Live Updates: Divis Labs Stock Details

Economic Times 4 hrs ago·29 Jul 2026, 2:30 am

Divis Laboratories is currently trending in the stock market due to extensive live updates regarding its share price and corporate details. Investors are closely monitoring the company's performance metrics, trading volumes, and any recent announcements that might influence its market valuation.

For retail investors, this surge in interest highlights the importance of staying informed about the company's operational health and strategic direction. Understanding the factors driving the stock's movement is crucial for making sound investment decisions.

Moving forward, investors should focus on the company's quarterly earnings reports, expansion plans, and any regulatory developments. Keeping an eye on these key areas will provide clarity on the stock's future trajectory.